The problems of antithrombotic and first of all, anticoagulant therapy in patients with concomitant oncological and cardiovascular pathology, especially in gerontological practice, remain to be unsolved. The need to use anticoagulants is dictated by a high risk of thromboembolism in cancer patients combined with age-associated atrial fibrillation. The risk of hemorrhage increases with the age; moreover, there is a risk of dangerous drug interactions due to the need of polymorbid pathology treatment. Thus, the clinical situation sometimes creates difficulties in choosing a proper tactic in patient management and following the existing treatment standards.
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INtrODUctION
High risk of thromboembolic complications and also tendency to hemorrhage in cancer patients, based on the development of the tumor itself and the ongoing anti-cancer treatment, is well known. At the same time, the issues of antithrombotic and first of all anticoagulant therapy in these patients remain unsolved.
However, if the risk of thromboembolism in cancer patients is combined with other risk factors, such as elderly age and age-associated atrial fibrillation (AF), more difficulties in clinical practice can occur. Vital functions support, including mechanical ventilation in an intensive care unit, was carried out. Six day after the low molecular weight heparin therapy was assigned. In this patient epicardial clipping of the left atrial appendage (LAA) or electrical isolation of the left atrial appendage with device occlusion for prevention of stroke could be considered, but given the small period of time between the hemorrhagic and ischemic strokes, the cancellation of anticoagulant therapy, these method couldn't be done.
Moreover, despite the high risk of thromboembolism in patients with atrial fibrillation and oncological process, there are no straight recommendations about using left atrial appendage method in this category of patients, especially in such an acute phase. There is also a need to consider the high risk of bleeding in cancer patients, when one of the most important limitations in LAA ligation are the potential risks of atrial tears and related bleeding [3, 4] .
cONclUsION
The study of comorbid cardiac and oncological patients' management issues, especially in gerontological practice, should be a priority research area in cardiooncology, and given the interdisciplinary nature of the problem, the proper algorithm of treatment should be developed individually and with the involvement of a cardiooncological team.
